FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA moves toward easing restrictions on certain peptides BioPharma Dive An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Future of Supercharging Healing and Performance with BPC 157 Regenerative Medicine Center Dr. Valerie Donaldson MD Pittsburgh, Pennsylvania PA